Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Inhaled insulin for controlling blood glucose in patients with diabetes Silverman BL; Barnes CJ; Campaigne BN; Muchmore DBVasc Health Risk Manag 2007[]; 3 (6): 947-58Diabetes mellitus is a significant worldwide health problem, with the incidence of type 2 diabetes increasing at alarming rates. Insulin resistance and dysregulated blood glucose control are established risk factors for microvascular complications and cardiovascular disease. Despite the recognition of diabetes as a major health issue and the availability of a growing number of medications designed to counteract its detrimental effects, real and perceived barriers remain that prevent patients from achieving optimal blood glucose control. The development and utilization of inhaled insulin as a novel insulin delivery system may positively influence patient treatment adherence and optimal glycemic control, potentially leading to a reduction in cardiovascular complications in patients with diabetes.|Administration, Inhalation[MESH]|Cardiovascular Diseases/physiopathology[MESH]|Contraindications[MESH]|Diabetes Mellitus/*drug therapy/physiopathology[MESH]|Drug Delivery Systems[MESH]|Glycated Hemoglobin/analysis[MESH]|Humans[MESH]|Hypoglycemic Agents/*administration & dosage[MESH]|Insulin/*administration & dosage[MESH]|Patient Education as Topic[MESH]|Patient Satisfaction[MESH]|Postprandial Period[MESH] |